This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Harvard College. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Avram Lev Robinson-Mosher: Innovator in Cancer Treatment
Introduction
Avram Lev Robinson-Mosher is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work on fusion proteins. With a total of 3 patents, his research focuses on developing methods to combat cancer effectively.
Latest Patents
One of his latest patents involves fusion proteins designed for treating cancer. These proteins bind to cells that express specific target molecules, such as cell surface multisubunit signaling receptors. For instance, they target EGFRvIII-expressing cells that also express interferon receptors, inducing anti-proliferative effects. This patent outlines related compositions and methods aimed at improving cancer treatment outcomes.
Career Highlights
Throughout his career, Avram has worked with prestigious institutions, including Harvard College and Dana-Farber Cancer Institute. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Avram has collaborated with notable colleagues, including Jeffrey Charles Way and Jean Zhao. These partnerships have further enriched his research and innovation in the field of cancer treatment.
Conclusion
Avram Lev Robinson-Mosher is a dedicated inventor whose work in developing fusion proteins for cancer treatment showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
